103 related articles for article (PubMed ID: 1919444)
1. The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins.
Aruffo A; Melnick MB; Linsley PS; Seed B
J Exp Med; 1991 Oct; 174(4):949-52. PubMed ID: 1919444
[TBL] [Abstract][Full Text] [Related]
2. The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host.
Coppi A; Natarajan R; Pradel G; Bennett BL; James ER; Roggero MA; Corradin G; Persson C; Tewari R; Sinnis P
J Exp Med; 2011 Feb; 208(2):341-56. PubMed ID: 21262960
[TBL] [Abstract][Full Text] [Related]
3. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion.
Braun M; Müller B; ter Meer D; Raffegerst S; Simm B; Wilde S; Spranger S; Ellwart J; Mosetter B; Umansky L; Lerchl T; Schendel DJ; Falk CS
J Innate Immun; 2011; 3(4):420-34. PubMed ID: 21178331
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of Murine Collagen-Induced Arthritis by Targeting CD6.
Li Y; Ruth JH; Rasmussen SM; Athukorala KS; Weber DP; Amin MA; Campbell PL; Singer NG; Fox DA; Lin F
Arthritis Rheumatol; 2020 Sep; 72(9):1505-1513. PubMed ID: 32307907
[TBL] [Abstract][Full Text] [Related]
5. CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies.
Aragón-Serrano L; Carrillo-Serradell L; Planells-Romeo V; Isamat M; Velasco-de Andrés M; Lozano F
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139340
[TBL] [Abstract][Full Text] [Related]
6. CD6 triggers actomyosin cytoskeleton remodeling after binding to its receptor complex.
Borjini N; Lun Y; Jang GF; Crabb J; Chen Y; Crabb J; Fox DA; Ivanov AI; Lin F
J Leukoc Biol; 2024 Feb; 115(3):450-462. PubMed ID: 37820034
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cell-associated migrasomes: a new source of chemoattractant for cells of hematopoietic origin.
Deniz IA; Karbanová J; Wobus M; Bornhäuser M; Wimberger P; Kuhlmann JD; Corbeil D
Cell Commun Signal; 2023 Feb; 21(1):36. PubMed ID: 36788616
[TBL] [Abstract][Full Text] [Related]
8. CD6-mediated inhibition of T cell activation via modulation of Ras.
Henriques SN; Oliveira L; Santos RF; Carmo AM
Cell Commun Signal; 2022 Nov; 20(1):184. PubMed ID: 36414966
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation.
Rambaldi B; Kim HT; Arihara Y; Asano T; Reynolds C; Manter M; Halpern M; Weber A; Koreth J; Cutler C; Gooptu M; Nikiforow S; Ho VT; Antin JH; Romee R; Ampudia J; Ng C; Connelly S; Soiffer RJ; Ritz J
Haematologica; 2022 Nov; 107(11):2617-2629. PubMed ID: 35484649
[TBL] [Abstract][Full Text] [Related]
10. Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.
Sánchez-Maldonado JM; Cáliz R; López-Nevot MÁ; Cabrera-Serrano AJ; Moñiz-Díez A; Canhão H; Ter Horst R; Quartuccio L; Sorensen SB; Glintborg B; Hetland ML; Filipescu I; Pérez-Pampin E; Conesa-Zamora P; Swierkot J; den Broeder AA; De Vita S; Petersen ERB; Li Y; Ferrer MA; Escudero A; Netea MG; Coenen MJH; Andersen V; Fonseca JE; Jurado M; Bogunia-Kubik K; Collantes E; Sainz J
Front Immunol; 2021; 12():672255. PubMed ID: 34777329
[TBL] [Abstract][Full Text] [Related]
11. CD6 is a target for cancer immunotherapy.
Ruth JH; Gurrea-Rubio M; Athukorala KS; Rasmussen SM; Weber DP; Randon PM; Gedert RJ; Lind ME; Amin MA; Campbell PL; Tsou PS; Mao-Draayer Y; Wu Q; Lanigan TM; Keshamouni VG; Singer NG; Lin F; Fox DA
JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33497367
[TBL] [Abstract][Full Text] [Related]
12. Biophysical Characterization of CD6-TCR/CD3 Interplay in T Cells.
Meddens MBM; Mennens SFB; Celikkol FB; Te Riet J; Kanger JS; Joosten B; Witsenburg JJ; Brock R; Figdor CG; Cambi A
Front Immunol; 2018; 9():2333. PubMed ID: 30356797
[TBL] [Abstract][Full Text] [Related]
13. CD318 is a ligand for CD6.
Enyindah-Asonye G; Li Y; Ruth JH; Spassov DS; Hebron KE; Zijlstra A; Moasser MM; Wang B; Singer NG; Cui H; Ohara RA; Rasmussen SM; Fox DA; Lin F
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6912-E6921. PubMed ID: 28760953
[TBL] [Abstract][Full Text] [Related]
14. Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses.
Carrasco E; Escoda-Ferran C; Climent N; Miró-Julià C; Simões IT; Martínez-Florensa M; Sarukhan A; Carreras E; Lozano F
Front Immunol; 2017; 8():769. PubMed ID: 28713387
[TBL] [Abstract][Full Text] [Related]
15. Relevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and Tolerance.
Consuegra-Fernández M; Martínez-Florensa M; Aranda F; de Salort J; Armiger-Borràs N; Lozano T; Casares N; Lasarte JJ; Engel P; Lozano F
Front Immunol; 2017; 8():594. PubMed ID: 28611770
[TBL] [Abstract][Full Text] [Related]
16. The scavenging capacity of DMBT1 is impaired by germline deletions.
Bikker FJ; End C; Ligtenberg AJM; Blaich S; Lyer S; Renner M; Wittig R; Nazmi K; van Nieuw Amerongen A; Poustka A; Veerman ECI; Mollenhauer J
Immunogenetics; 2017 Jun; 69(6):401-407. PubMed ID: 28364129
[TBL] [Abstract][Full Text] [Related]
17. CD6 as a potential target for treating multiple sclerosis.
Li Y; Singer NG; Whitbred J; Bowen MA; Fox DA; Lin F
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2687-2692. PubMed ID: 28209777
[TBL] [Abstract][Full Text] [Related]
18. Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab.
Aira LE; López-Requena A; Fuentes D; Sánchez L; Pérez T; Urquiza A; Bautista H; Falcón L; Hernández P; Mazorra Z
MAbs; 2014; 6(3):783-93. PubMed ID: 24594862
[TBL] [Abstract][Full Text] [Related]
19. A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis.
Rodriguez PC; Torres-Moya R; Reyes G; Molinero C; Prada D; Lopez AM; Hernandez IM; Hernandez MV; Martinez JP; Hernandez X; Casaco A; Ramos M; Avila Y; Barrese Y; Montero E; Hernandez P
Results Immunol; 2012; 2():204-11. PubMed ID: 24371585
[TBL] [Abstract][Full Text] [Related]
20. Fine mapping and functional analysis of the multiple sclerosis risk gene CD6.
Swaminathan B; Cuapio A; Alloza I; Matesanz F; Alcina A; García-Barcina M; Fedetz M; Fernández O; Lucas M; Orpez T; Pinto-Medel MJ; Otaegui D; Olascoaga J; Urcelay E; Ortiz MA; Arroyo R; Oksenberg JR; Antigüedad A; Tolosa E; Vandenbroeck K
PLoS One; 2013; 8(4):e62376. PubMed ID: 23638056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
